telmisartan has been researched along with Ventricular Dysfunction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kagota, S; Kunitomo, M; Maruyama, K; Nakamura, K; Shinozuka, K; Tada, Y; Wakuda, H | 1 |
Frohlich, ED; Susic, D | 1 |
2 other study(ies) available for telmisartan and Ventricular Dysfunction
Article | Year |
---|---|
Abnormal amounts of intracellular calcium regulatory proteins in SHRSP.Z-Lepr(fa)/IzmDmcr rats with metabolic syndrome and cardiac dysfunction.
Topics: Animals; Benzimidazoles; Benzoates; Blood Glucose; Body Weight; Calcium; Calcium-Binding Proteins; Cholesterol; Coronary Circulation; Diastole; Disease Models, Animal; Heart Function Tests; Insulin; Male; Metabolic Syndrome; Myocytes, Cardiac; Phosphorylation; Rats; Rats, Inbred Strains; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Serine; Telmisartan; Triglycerides; Ventricular Dysfunction; Ventricular Function, Left | 2013 |
Telmisartan improves survival and ventricular function in SHR rats with extensive cardiovascular damage induced by dietary salt excess.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Body Weight; Diastole; Disease Models, Animal; Hypertension; Hypertrophy, Left Ventricular; Male; Random Allocation; Rats, Inbred SHR; Sodium, Dietary; Telmisartan; Ventricular Dysfunction | 2014 |